An active surveillance to monitor the real world safety in Indian patients prescribed nintedanib for the treatment of Idiopathic Pulmonary Fibrosis

04/01/2017
22/02/2024
EU PAS number:
EUPAS17055
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

clinical-trial-protocol-amendment-01_2

English (459.06 KB - PDF) View document
Updated protocol

1199-0280-Protocol-V5

First published: 22/02/2024
English (663.7 KB - PDF) View document
Study results
Study results

1199-0280-NIS Report

English (224.01 KB - PDF) View document
Study report
Other information